Author(s):
Amol V. Sawale, Vidhi Sunil Jajoo, Anuj A. Deshmukh
Email(s):
amol.sawale29@gmail.com , vidhijajoo9764@gmail.com , profanujdeshmukh@gmail.com
DOI:
10.52711/2349-2988.2024.00029 
Address:
Amol V. Sawale1*, Vidhi Sunil Jajoo2, Anuj A. Deshmukh1
1Assistant Professor, Vidyabharati College of Pharmacy, Naidu Marg Camp, Amravati, MH India 444602.
2Student, Vidyabharati College of Pharmacy, Naidu Marg Camp, Amravati, MH India 444602.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2024
ABSTRACT:
The chrono-pharmacology is a branch of chronobiology that focuses on the investigation of pharmacological properties. These studies take into consideration how the medication response varies over time. Some disorders do not require constant medication release; instead, sometimes require for pulsatile drug release at predetermined intervals. This method led to the development of the pulsatile drug delivery system (PDDS). After a predetermined amount of medication has been released, this technique primarily involves the rapid release of a fixed quantity of drug moiety. The purpose of the proposed research is to develop an oral pulsatile release drug delivery system of Tramadol HCL that will be effective in the chronotherapeutic control of arthritic pain using opioid analgesics. Strong painkiller tramadol is used to treat moderate to severe pain that is not being treated by other painkillers. A synthetic opioid, tramadol operates on the brain and spine (central nervous system) to reduce the feeling of pain. The melting point of tramadol HCL has been determined to be between 180 and 181°C. The drug's highest absorption was at 270.50nm in wavelength. The optimized results are shown in the formulas F1 to F3.
Cite this article:
Amol V. Sawale, Vidhi Sunil Jajoo, Anuj A. Deshmukh. Formulation and Evaluation of Pulsatile Drug Delivery System for the Treatment of Arthritic Pain. Research Journal of Science and Technology. 2024; 16(3):193-2. doi: 10.52711/2349-2988.2024.00029
Cite(Electronic):
Amol V. Sawale, Vidhi Sunil Jajoo, Anuj A. Deshmukh. Formulation and Evaluation of Pulsatile Drug Delivery System for the Treatment of Arthritic Pain. Research Journal of Science and Technology. 2024; 16(3):193-2. doi: 10.52711/2349-2988.2024.00029 Available on: https://rjstonline.com/AbstractView.aspx?PID=2024-16-3-5
REFERENCES:
1. B Botti, C You an. Chrono Pharmaceutics: Gimmick or Clinically relevant approach to drug delivery. Journal Control Release. 2004; 98: 337-353.
2. Gandhi BR, Mundada AS, Gandhi PP. Chrono Pharmaceutics: As a clinically relevant drug delivery. System. Drug Delivery. 2011, 18(1): 1–18.
3. Janugade BU Patil SS., Patil SV, Lade PD. Pulsatile drug delivery system for chronopharmacological disorders: an overview. Journal of Pharmacy Research. 2009; 2(1): 132-143.
4. Javed Ali, Sanjula Baboota, Alka Ahuja, Nitin Saigal. Distinctive features of “chronotherapeutic” and pulsatile” drug delivery systems negating the practice of their interchangeable terminology. Journal of Drug Targeting. 2010; 18(6): 413–419.
5. Alessandra Maroni, Lucia Zema, Maria Dorly Del Curto, Giulia Loreti, Andrea Gazzaniga. Oral pulsatile delivery: Rationale and chronopharmaceutical formulations. International Journal of Pharmaceutics. 2010; 3981–8.
6. Michael H. Smolensky, Nicholas A. Peppasb. Chronobiology, drug delivery, and chronotherapeutic. Advanced Drug Delivery Reviews. 2007; 59: 828–851
7. Erhard Haus. Chronobiology in the endocrine system. Advanced Drug Delivery Reviews. 2007; 59 :985–1014.
8. Zaheeda Khan, Viness Pillay, Yahya E. Choonara, Lisa C. du Toit. Drug delivery technologies for chronotherapeutic applications. Pharmaceutical Development and Technology. 2009; 14(6): 602–612.
9. Sachin Survase, Neeraj Kumar. Pulsatile drug delivery: Current scenario. CRIPS. 2007; 8(2): 27-33.
10. Hitesh Dalvadi, Jayvadan K Patel. Chronopharmaceutics, Pulsatile drug delivery system as current trend. Chronopharmaceutics Asian Journal of Pharmaceutical Sciences. 2010;;5 (5): 204-230.
11. P. Roy, A. Shahiwala. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. Journal Control Release. 2009; 134:74-80.
12. Shiwani Sharma, Anshul Dutt Sharma, Roopa Saharawat. Pulsatile drug delivery system: a review an advanced approach: Review Article. International Journal of Pharmacy &Technology. 2011; 3(2): 1179-1188.
13. Patel GC, Patel MM. A comparative in vitro evaluation of enteropolymers for pulsatile drug delivery system. Acta Pharmaceuticasciencia. 2009; 51:243-50.
14. Dabhi C, Randale S, Belgamwar V, Gattani S, Tekade A. Predictable pulsatile release of tramadol hydrochloride for chronotherapeutics of arthritis. Drug Deliv. 2010;17(5): 273-81.
15. Saluja V, Garg C. Once-daily sustained-release matrix tablets of metformin hydrochloride based on an enteric polymer and chitosan. J. Pharm. Educ. Res. 2013; 4: 92-7.
16. Udayakumar T, Suresh AG, Ubaidulla U. Formulation and evaluation of immediate and sustained release bilayered tablet with glibenclamide and metformin HCl. Int J Res Dev Pharm Sci. 2013; 2:337-43.
17. Shashidhar P, Vidya Sagar G, Srikanth G. Design and in-vitro evaluation of metformin hydrochloride (SR) and glimepiride (IR) as bilayered tablets. Int J Pharm Chem Sci. 2013; 2:780-92.
18. Collet J., Moreton C., Modified-release per oral dosage forms, In: Alton ME, editor. Pharmaceutics: Science of Dosage Form Design. United Kingdom: Churchill Livingstone; International Journal of Pharmaceutics. 2002; 1: 665-669.
19. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy.3rd ed. Mumbai: Vargheese Publishing House; 1991. p.296-302.
20. Indian Pharmacopoeia, Government of India, Ministry of Health and Family Welfare. Delhi: Controller of Publications; 1996. Vol 2. p. 182.
21. United State Pharmacopeia 31, The National Formulary. US Pharmacopeial Convention. Washington DC: Board of Trustees publication; 2008. Vol1. p. 272
22. Ganesh Kumar Y, Sreekanth J, Satyavati D, Chaitanya P, Swetha B. Formulation design and in vitro evaluation of sustained release matrix tablets of losartan potassium using HPMC polymers. Int J Pharm Tech Res. 2013; 5: 1332-44.
23. Dinesh Kumar M, Jain DK. Formulation and evaluation of valsartan sustained release matrix tablets. Bull Pharm Res. 2014; 4:81-5.